Characteristics | Training set (n = 72) | Testing set (n = 31) | ||||
---|---|---|---|---|---|---|
Low-grade (n = 28) | High-grade (n = 44) | P value | Low-grade (n = 12) | High-grade (n = 19) | P value | |
Age | 70.29 ± 8.19 | 66.43 ± 11.12 | 0.119 | 65.33 ± 11.48 | 64.11 ± 11.72 | 0.777 |
Gender | Â | Â | 0.714 | Â | Â | 0.178 |
 Female | 9 | 16 |  | 1 | 7 |  |
 Male | 19 | 28 |  | 11 | 12 |  |
Tumor long axis | 4.53 ± 2.73 | 5.39 ± 2.85 | 0.209 | 3.60 ± 1.71 | 5.66 ± 3.55 | 0.039 |
pT stage | Â | Â | 0.005 | Â | Â | 0.025 |
 T1 | 5 | 0 |  | 5 | 0 |  |
 T2 | 4 | 5 |  | 0 | 1 |  |
 T3 | 5 | 4 |  | 2 | 4 |  |
 T4 | 14 | 35 |  | 5 | 14 |  |
pN stage |  |  |  < 0.001 |  |  |  < 0.001 |
 N0 | 11 | 6 |  | 6 | 1 |  |
 N1 | 5 | 2 |  | 2 | 1 |  |
 N2 | 7 | 17 |  | 3 | 4 |  |
 N3 | 5 | 29 |  | 1 | 13 |  |
Location | Â | Â | 0.115 | Â | Â | 0.278 |
 Upper 1/3 | 10 | 10 |  | 3 | 4 |  |
 Middle 1/3 | 10 | 14 |  | 5 | 5 |  |
 Lower 1/3 | 7 | 16 |  | 4 | 7 |  |
 Multiple | 1 | 4 |  | 0 | 3 |  |
AFP | Â | Â | 1.000 | Â | Â | 1.000 |
 Normal | 26 | 41 |  | 12 | 19 |  |
 Abnormal | 2 | 3 |  | 0 | 0 |  |
CEA | Â | Â | 0.147 | Â | Â | 1.000 |
 Normal | 23 | 42 |  | 12 | 19 |  |
 Abnormal | 5 | 2 |  | 0 | 0 |  |
CA125 | Â | Â | 0.884 | Â | Â | 0.510 |
 Normal | 25 | 41 |  | 12 | 17 |  |
 Abnormal | 3 | 3 |  | 0 | 2 |  |
CA19-9 | Â | Â | 0.553 | Â | Â | 0.409 |
 Normal | 22 | 37 |  | 7 | 15 |  |
 Abnormal | 6 | 7 |  | 5 | 4 |  |
CA72-4 | Â | Â | 0.620 | Â | Â | 0.510 |
 Normal | 23 | 34 |  | 12 | 17 |  |
 Abnormal | 5 | 10 |  | 0 | 2 |  |
CA153 | Â | Â | 1.000 | Â | Â | 1.000 |
 Normal | 27 | 43 |  | 12 | 19 |  |
 Abnormal | 1 | 1 |  | 0 | 0 |  |